---
title: Ajinomoto Bio-Pharma Services vs Divi's Laboratories
slug_a: ajibio-pharma
slug_b: divislabs
site: cdmo
review_signal_gate: closed
canonical_path: /compare/ajibio-pharma/divislabs
---

# Ajinomoto Bio-Pharma Services vs Divi's Laboratories

Side-by-side profile data from each company listing on this directory.

## Ajinomoto Bio-Pharma Services

- Profile: [/companies/ajibio-pharma](/companies/ajibio-pharma)

Ajinomoto Bio-Pharma Services — Ajinomoto Bio-Pharma Services is a global contract development and manufacturing organization (CDMO) dedicated to improving the health of humankind through adaptive solutions and responsive service.

Services: 8. Modalities: 6. Indications: 0. Locations: 4. Certifications: 0. The strongest documented coverage currently appears in services (8).

### Services

- Small Molecule Development & Manufacturing
- Biologics Development & Manufacturing
- ADC (Antibody-Drug Conjugate) Manufacturing
- Oligonucleotide Manufacturing
- Peptide Manufacturing
- Process Development
- CMC Analytical Development
- Quality Control Testing

### Modalities

- Small Molecule
- Biologics (Other)
- Antibody-Drug Conjugate (ADC)
- Oligonucleotide
- Gene Therapy
- Peptide

### Development capabilities

- Data not yet provided.

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)

## Divi's Laboratories

- Profile: [/companies/divislabs](/companies/divislabs)

Divi's Laboratories — World's largest API manufacturer and trusted CDMO partner for 25+ years, offering generic APIs, custom synthesis, peptides, and nutraceutical ingredients to 100+ countries with complete backward integration and green chemistry principles.

Services: 9. Modalities: 2. Indications: 0. Locations: 7. Certifications: 0. The strongest documented coverage currently appears in services (9).

### Services

- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- HPAPI Manufacturing (High-Potency)
- Peptide Manufacturing
- Process Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- CMC Regulatory Submission Support

### Modalities

- Small Molecule
- Peptide

### Development capabilities

- Analytical method development
- Formulation development

### Manufacturing capabilities

- Drug Substance (DS)
- Max chemical: Commercial (>100 kg / tonne)
- HPAPI
- Flow Chemistry